Correlation Between GlucoTrack and Boston Scientific
Can any of the company-specific risk be diversified away by investing in both GlucoTrack and Boston Scientific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and Boston Scientific into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlucoTrack and Boston Scientific Corp, you can compare the effects of market volatilities on GlucoTrack and Boston Scientific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of Boston Scientific. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and Boston Scientific.
Diversification Opportunities for GlucoTrack and Boston Scientific
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between GlucoTrack and Boston is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and Boston Scientific Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Scientific Corp and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with Boston Scientific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Scientific Corp has no effect on the direction of GlucoTrack i.e., GlucoTrack and Boston Scientific go up and down completely randomly.
Pair Corralation between GlucoTrack and Boston Scientific
Given the investment horizon of 90 days GlucoTrack is expected to under-perform the Boston Scientific. In addition to that, GlucoTrack is 23.38 times more volatile than Boston Scientific Corp. It trades about -0.27 of its total potential returns per unit of risk. Boston Scientific Corp is currently generating about 0.55 per unit of volatility. If you would invest 9,595 in Boston Scientific Corp on November 9, 2024 and sell it today you would earn a total of 907.00 from holding Boston Scientific Corp or generate 9.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlucoTrack vs. Boston Scientific Corp
Performance |
| Timeline |
| GlucoTrack |
| Boston Scientific Corp |
GlucoTrack and Boston Scientific Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlucoTrack and Boston Scientific
The main advantage of trading using opposite GlucoTrack and Boston Scientific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, Boston Scientific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will offset losses from the drop in Boston Scientific's long position.| GlucoTrack vs. Nexgel Inc | GlucoTrack vs. Avinger | GlucoTrack vs. Sharps Technology | GlucoTrack vs. Innovative Eyewear |
| Boston Scientific vs. Stryker | Boston Scientific vs. Abbott Laboratories | Boston Scientific vs. Medtronic PLC | Boston Scientific vs. DexCom Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |